Nicholas Pajewski to Wet Macular Degeneration
This is a "connection" page, showing publications Nicholas Pajewski has written about Wet Macular Degeneration.
Connection Strength
0.606
-
Gower EW, Stein JD, Shekhawat NS, Mikkilineni S, Blachley TS, Pajewski NM. Geographic and Demographic Variation in Use of Ranibizumab Versus Bevacizumab for Neovascular Age-related Macular Degeneration in the United States. Am J Ophthalmol. 2017 Dec; 184:157-166.
Score: 0.606